To Test 2 Doses of GSK Biologicals’ Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in co-Administration With Specific Childhood Vaccines
This study has been completed.
Study NCT00140686
Information provided by GlaxoSmithKline
First Received: August 31, 2005
Last Updated: February 12, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: